OASIS® Wound Matrix | Patient Information | Contact Us | Instructions for Use


Triple-layer OASIS® Ultra —
Preparing the Way in Problematic Wounds

OASIS® Ultra provides triple the structure for
problematic wounds

Three layers of bioresorbable extracellular matrix (ECM) incorporate increased structure into the wound

OASIS Wound Matrix is an intact matrix naturally derived

  • In a healthy body, the ECM is the structural component that surrounds cells and binds them in tissue1,2

 

Naturally derived, intact porcine small intestinal submucosa (SIS)

  • SIS technology is proven to help the body replace or repair damaged tissue3,4

    • SIS is the most widely studied and published biomaterial, featured in more than 832 scientific publications3

    • SIS research currently includes more than 244 human studies3

 

Triple-layer structure for improved fixation5

Difference between OASIS Wound Matrix and OASIS Ultra

 

Designed with surgeons in mind

  • Extra thickness offers easier handling and application

  • Easy to trim to the exact size and shape of the wound

  • Increased strength and thickness allow for easier fixation, including sutures and staples (if indicated)

 

Retains multiple components found in the human dermis6

  • OASIS® Ultra is minimally processed and sterilized through the use of a proprietary method that retains key collagen and non-collagen components4,6

 

OASIS Wound Matrix is an intact matrix naturally derived
*Components identified in vivo (nonhuman) and/or in vitro.
†Present in SIS cultured with cells.
GAGs=glycosaminoglycans; HSPG=heparin sulfate proteoglycan

 

Designed specifically for a broad range of problematic wounds

OASIS Wound Matrix is an intact matrix naturally derived

 

OASIS® Ultra is indicated for the management of:

  • Surgical wounds

    • Donor sites/grafts

    • Post-Mohs’ surgery

    • Post-laser surgery

    • Podiatric

    • Wound dehiscence

  • Partial- and full-thickness wounds

  • Trauma wounds (including second-degree burns)

  • Venous ulcers

  • Chronic vascular ulcers

  • Diabetic ulcers

  • Pressure ulcers

  • Draining wounds

 

 
  • Contraindications: This device is derived from a porcine source and should not be used in patients with known sensitivity to porcine material. This device is not indicated for use in third-degree burns

References: 1. MacNeil S. What role does the extracellular matrix serve in skin grafting and wound healing? Burns. 1994;20 (Suppl 1):S67-S70. 2. Clark RA. Basics of cutaneous wound repair. J Dermatol Surg Oncol. 1993;19;693-706. 3. Available at: http://www.cookbiotech.com. Accessed November 8, 2010. 4. Brown-Etris M, Cutshall WD, Hiles MC. A new biomaterial derived from small intestine submucosa and developed into a wound matrix device. Wounds. 2002;14:150-166. 5. In-vitro data on file, Healthpoint, Ltd. 6. Data on file, Cook Biotech, Inc.


OASIS is a registered trademark of Cook Biotech, Inc. Healthpoint is a registered trademark of Healthpoint, Ltd.
© 2011 Healthpoint Biotherapeutics. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in the United States only. All information, including the Prescribing Information for OASIS® Wound Matrix and OASIS® Ultra, abides by the laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States.

For help with reimbursement questions, please call our national hotline at 1-877-805-5055 between 9AM - 7PM EST Monday through Friday.